SCHEMBL4896320

SCHEMBL4896320

CCc1nc(NC(=O)C2COc3ccccc3O2)c(C(=O)OC)n1C

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.54
HTT P42858 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
HPGD P15428 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
TSHR P16473 4/20 0.53
MAPT P10636 1/20 0.53
ALOX15 P16050 1/20 0.53
HSD17B10 Q99714 1/20 0.53
NPC1 O15118 8/20 0.52
RAB9A P51151 5/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPK10 P53779 1/20 0.51
BLM P54132 1/20 0.49
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4892082 0.78 MAPT (0.47) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL4886948 0.74 TSHR (0.53) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL4892866 0.73 SMN1; SMN2 (0.46) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL4508777 0.70 L3MBTL1 (0.66) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL4789183 0.70 NPC1 (0.49) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL3288928 0.69 L3MBTL1 (0.46) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL11013240 0.68 HPGD (0.75) L3MBTL1HTTALDH1A1KDM4EHPGD
SCHEMBL4896089 0.68 L3MBTL1 (0.46) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL4892548 0.68 MAPT (0.47) L3MBTL1HTTNPSR1ALDH1A1KDM4E
SCHEMBL3441603 0.68 L3MBTL1 (0.48) L3MBTL1HTTNPSR1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US claimed
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US disclosed
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US disclosed
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators GABRB1, GABBR2, GABRB2 L3MBTL1 2853/4885HTT 4375/4885NPSR1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.